SCHEMBL7932291

SCHEMBL7932291

CSc1ccc(/C=C2\C(C)=C(CO)c3cc(F)ccc32)cc1

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 10/20 0.74
CYP1A2 P05177 3/20 0.74
MAPT P10636 3/20 0.74
MAPK1 P28482 3/20 0.74
PTGS2 P35354 2/20 0.74
TDP1 Q9NUW8 2/20 0.74
PTGS1 P23219 2/20 0.74
EGFR P00533 1/20 0.74
ADORA3 P0DMS8 1/20 0.74
DRD1 P21728 1/20 0.74
OPRM1 P35372 1/20 0.74
PSEN1 P49768 1/20 0.74
PSEN2 P49810 1/20 0.74
APH1B Q8WW43 1/20 0.74
NCSTN Q92542 1/20 0.74
APH1A Q96BI3 1/20 0.74
PSENEN Q9NZ42 1/20 0.74
CYSLTR1 Q9Y271 1/20 0.74
PTGDR2 Q9Y5Y4 1/20 0.74
RXRA P19793 5/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7932296 1.00 PPARG (0.74) PPARGCYP1A2MAPTMAPK1PTGS2
SCHEMBL7932283 1.00 PPARG (0.74) PPARGCYP1A2MAPTMAPK1PTGS2
SCHEMBL7920389 0.90 PPARG (0.71) PPARGCYP1A2MAPTMAPK1PTGS2
SCHEMBL7920387 0.90 PPARG (0.71) PPARGCYP1A2MAPTMAPK1PTGS2
SCHEMBL7920390 0.90 PPARG (0.71) PPARGCYP1A2MAPTMAPK1PTGS2
SCHEMBL7926179 0.89 PPARG (0.73) PPARGCYP1A2MAPTMAPK1PTGS2
SCHEMBL7926176 0.89 PPARG (0.73) PPARGCYP1A2MAPTMAPK1PTGS2
SCHEMBL7926171 0.89 PPARG (0.73) PPARGCYP1A2MAPTMAPK1PTGS2
SCHEMBL17826435 0.88 PPARG (0.71) PPARGCYP1A2MAPTMAPK1PTGS2
SCHEMBL7920358 0.86 PPARG (0.70) PPARGCYP1A2MAPTMAPK1PTGS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6300346-B1 THERAPY OF PRECANCEROUS LESIONS COMPRISING ADMINISTERING INDENYL HYDROXAMIC ACID DERIVATIVE COMPOUND CELL PATHWAYS, INC. 2001-10-09 US disclosed
US-6071934-A PREVENTING TUMORS OR SLOWING THEIR GROWTH CELL PATHWAYS, INC. (US) 2000-06-06 US disclosed
US-5093356-A Antiallergens, antiasthma, antiinflammatory, cytoprotective MERCK FROSST CANADA, INC. (CA) 1992-03-03 US disclosed